Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v3.22.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Cost of Common Stock in Treasury
Beginning balance at Dec. 31, 2019 $ 106,511 $ (450) $ 10,300 $ 37,407 $ 70,552 $ (450) $ (11,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (27,267)       (27,267)    
Issuance of shares of common stock from the treasury 345     (1,479)     1,824
Share-based compensation 1,791     1,791      
Purchase of common stock (635)           (635)
Ending balance at Dec. 31, 2020 80,295   10,300 37,719 42,835   (10,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 20,245       20,245    
Issuance of shares of common stock from the right offering 10,010   785 9,225      
Issuance of shares of common stock from the treasury 132     (1,670)     1,802
Exercise of stock options , net 109     (15)     124
Share-based compensation 799     799      
Ending balance at Dec. 31, 2021 $ 111,590   $ 11,085 $ 46,058 $ 63,080   $ (8,633)